Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am, go to: https://goo.gl/O3l5KC use the password: freechatfriday
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Loading BIIB News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 4.42% | 70.48 | 0.9% | $642.57m | |
| CELG | Celgene Corporation | 0.64% | 133.68 | 1.1% | $633.67m | |
| AMGN | Amgen Inc. | 1.44% | 173.82 | 1.1% | $633.64m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.14% | 126.23 | 1.9% | $553.94m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.86% | 526.53 | 2.7% | $546.91m | |
| BIIB | Biogen Inc. | 0.71% | 280.57 | 1.2% | $499.28m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.52% | 135.53 | 1.9% | $281.36m | |
| INCY | Incyte Corporation | 1.22% | 135.63 | 2.6% | $274.50m | |
| CLVS | Clovis Oncology, Inc. | 2.64% | 96.78 | 18.0% | $248.18m | |
| TSRO | TESARO, Inc. | 5.38% | 149.77 | 14.7% | $231.38m | |
| PBYI | Puma Biotechnology, Inc. | 7.73% | 86.45 | 21.1% | $188.33m | |
| ILMN | Illumina, Inc. | 3.16% | 182.99 | 3.5% | $163.69m | |
| BLUE | Bluebird Bio, Inc. | -1.50% | 118.50 | 19.3% | $156.72m | |
| A | Agilent Technologies, Inc. | 1.36% | 60.60 | 1.5% | $134.46m | |
| EXAS | Exact Sciences Corporation | -0.80% | 34.71 | 26.3% | $127.68m |
Company Profile
Biogen, Inc. is a global biotechnology company, which focuses on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded by Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.,00167Y-E